FT : Shire: Endgame to an Acquisition

Shire: Endgame to an Acquisition
First offer from AbbVie snubbed, but sweeter bids are likely.

It isn't too late to join the party at Shire, which looks to be in play after a tentative approach by AbbVie.

The biopharmaceutical company's London-listed shares (ticker: SHP.United Kingdom) have jumped about 30% in the past couple of weeks since AbbVie's (ABBV) interest was first disclosed, but there could be plenty more upside to come—especially if another bidder emerges. A knockout blow could be 20% to 30% above Friday's closing price of 45.70 British pounds ($77.86) a share.

Shire, which also has American depository receipts listed in New York under the ticker SHPG, may be entering the endgame. This isn't entirely unexpected: A shake-up has been taking place in pharmaceuticals this year, and Shire has long been considered a takeover target. The Stoxx Europe 600 health-care sector is up almost 14% in 2014, outperforming a gain of roughly 4% in the broader index.

Shire so far has spurned AbbVie's £27 billion proposal, which—unsurprisingly—it says fundamentally undervalues the company and its prospects. However, while Allergan (AGN) has thrown plenty of mud in its determined effort to fend off predator Valeant Pharmaceuticals International (VRX.Canada), Shire's defense against AbbVie has been cordial, even half-hearted. It suggests that Shire's board may be ready to talk if AbbVie gets closer to a valuation it considers realistic. An offer above £50 a share could be sufficient to open a dialogue.

AbbVie needs the combination more than Shire. Illinois-based AbbVie would move its domicile to Ireland, where Shire is based, allowing it to cut its tax bill from 22% to 13%, a major incentive. Tax inversion, or reincorporating overseas to benefit from lower taxes, makes European companies particularly attractive to U.S. buyers. At the same time, a deal would diversify AbbVie's portfolio, which currently is too heavily dependent on arthritis medicine Humira, the world's top-selling drug last year. The threat of growing competition for Humira may be a major motivation for AbbVie.

Shire has been quick to make the point that it is under no pressure to do a deal and its prospects as a stand-alone company are strong. Management presented the market with forecasts for sales to grow from under $4.9 billion in 2013 to $10 billion by 2020 based on its current portfolio, which comprises treatments for ADHD and rare diseases. The sales target looks optimistic, even exaggerated, but Shire is spreading a message that the figure doesn't include its most recent acquisitions or future purchases.

By emphasizing the company's potential, Shire is simply trying to extract the best possible price. AbbVie's indicative proposal of £46.26 per share in cash and stock values Shire at about 24 times forecast 2014 earnings of £1.91 per share. That looks cheap given Shire's double-digit compound annual growth rate in sales through 2018, a 35% operating margin that is expanding, and robust earnings.

The danger for AbbVie is that other bidders now could come forward. Allergan and AstraZeneca (AZN.United Kingdom), a target of a failed bid from Pfizer (PFE), are candidates as they try to protect themselves from current or future unwanted advances.

Ori Hershkowitz, a portfolio manager at Sphera Funds Management in Tel Aviv, believes Pfizer also could enter the fray. He invested 4% of his $500 million Sphera Global Healthcare fund in Shire a few months ago after Pfizer was rebuffed by AstraZeneca. He sees greater synergies between Shire and Pfizer than with AbbVie, but he isn't too concerned about a deal. "I would be happy to own Shire as a stand-alone company," he says. "It is a great company."

Bank of America Merrill Lynch estimates the value of Shire to AbbVie at between £50 and £62 per share, based on its long-range plans, tax, and synergy benefits. Most analysts see Shire's takeout price above £55 a share.

The clock is ticking for AbbVie. U.K. regulators have imposed a July 18 deadline for the company to make a bid for Shire or walk away. Rivals may be racing against time to beat AbbVie to the prize. Investors can't afford to ponder this situation for too long.

NORWAY'S $887 BILLION state pension fund plans to boost its investment in real estate and in frontier markets.

Norges Bank Investment Management, which administers the fund on the government's behalf, intends to increase its real estate exposure by 1% each year through 2016. That would take its property holdings to 5% of its portfolio, up from just 1.2% last year. Its concentration in Europe will be on London and Paris, while in the U.S. it will be on New York, Washington, Boston, and San Francisco.

Its holding of equities will fall to 60% in 2016 from 61.1%, and its fixed-income portfolio will shrink to 35% from 37.7%. The fund owns a 2.5% share of Europe's listed companies, and its top holdings include Nestle (NESN.Switzerland), Royal Dutch Shell (RDSB.United Kingdom), and Novartis (NOVN.Switzerland).

(ZH) Crushing The Q2 "Recovery" Dream In 1 Simple Chart


Crushing The Q2 "Recovery" Dream In 1 Simple Chart

For a week or two, the 'news' appeared to confirm the 'hope'; faith that Q1's dysphoria would emerge phoenix-like into Q2 euphoria as a 'hibernating' American public emerging from their weather-shelter and spent-spent-spent all their borrowed-borrowed-borrowed money. That ended last week! Despite the dramatically low volume liftathon in stocks since the FOMC meeting, major risk markets around the world are cracking. European bonds and stocks had a bad week, Treasuries rallied the most in 6 weeks, and the key to it all, USDJPY, slipped to 4 week lows. Why? As the chart below shows, US macro data is collapsing again (right on cue) and stands at 2-month lows... (and is the worst-performing macro nation in the world this year!)

 

 

But it's not just top-down that's "broken"...
as Bottom-up Fundamentals are no longer the driver for credit
or equity markets...

 

FT : Jacob Wallenberg troubled by Sweden’s ‘shift to the left’

Jacob Wallenberg troubled by Sweden’s ‘shift to the left’

Sweden’s leading industrialist has sounded the alarm over a likely leftward shift after September’s elections, warning it could lead entrepreneurs to flee the Nordic country.
Jacob Wallenberg, whose family foundations indirectly control nearly half of Stockholm’s stock exchange, told the Financial Times that “a massive shift to the left” in recent weeks worried him because it called into question reforms in Sweden over the past decade.
“If there is a new government and if they change the rules – be that on taxation, labour, a number of different things – the risk you are running is that you see entrepreneurs leaving the country or electing to do other things,” said Mr Wallenberg. He added that he and other business leaders wanted to see “predictability and stability”.

Sweden’s current centre-right government are on course for defeat in September’s elections after governing for eight years, according to opinion polls that make the centre-left Social Democrats the leading party. But the pro-industry Social Democrats will need the support of one or most likely both of the Greens and the Left Party.
Both have caused consternation in business circles by taking a far more radical tack than the Social Democrats. Mr Wallenberg pointed to policies such as the Green’s desire for a no-growth society and the Left Party’s repudiation of centre-right reforms that have brought in private equity companies to run school and hospitals.
“What do they want to do? They want to take away all the freedom choices we are talking about. They have a different view on the role of government. They think government should run things,” said Mr Wallenberg, who is a director of Ericsson, ABB, SAS as well as chairman of his family investment vehicle, Investor.
Many of Sweden’s best-known entrepreneurs – such as Ikea’s Ingvar Kamprad and Hans Rausing of Tetra Pak – left the country in the 1970s and 1980s as a result of high taxation. The centre-right government has cut income tax five times and scrapped the wealth tax, scoring a publicity coup when Mr Kamprad ended his tax exile in Switzerland this year.
The Greens – who were the second-biggest party in June’s European elections behind the Social Democrats – have proposed closing Stockholm’s central Bromma airport and stopping construction of a bypass around the capital.


Anders Borg, Sweden’s centre-right finance minister for the past eight years, told the Financial Times: “This is basically much more of a leftwing experiment than we have probably ever seen in Swedish history.”
But his likely successor, Magdalena Andersson of the Social Democrats, deflected the criticism and said her party would work with any other political grouping aside from the populist right Sweden Democrats. Asked about the Green’s no-growth policy and closure of Bromma, she added: “I think you are pointing to some of the reasons why the Green party might not be quite as big in national elections as they were in the European parliament elections.”
The most recent Ipsos opinion poll in June gave the three centre-left parties 49.8 per cent of the vote against 35.6 per cent for the four centre-right parties. The Social Democrats topped the polls with 31 per cent, followed by the governing Moderates with 21 per cent and the Greens with 11 per cent.
Outside of the two main groupings are the Sweden Democrats with 10 per cent and a new party, the Feminist Initiative, with 3.7 per cent, just below the threshold to enter parliament.

>>> Banca Popolare dell’Etruria contacts BPM for possible merger

Banca Popolare dell’Etruria contacts BPM for possible merger

Banca Popolare dell’Etruria, the listed, Italian bank, has contacted representatives of listed, Italian peer BPM for a potential merger.

This was reported by Italian-language daily Il Messaggero which quoted unnamed sources.

Etruria's Chairman Francesco Rosi, and his two deputies, Alfredo Berni and Pierluigi Boschi, had contacted representatives of BPM, the article noted. The report said that on Monday 30 June, there will be a board meeting of Etruria, where Rosi will provide an update on the potential merger candidates.

However, the report said that the heads of BPM, Piero Giarda, Mario Anolli and Giuseppe Castagna, want to consult with the Bank of Italy to get a potential go ahead. Lazard and Rothschild are advising Etruria, the article added.

Meanwhile, the report said that BPM could consider a merger with Creval but only starting 2015. At the same time, Etruria has also contacted BPER for a possible merger, the report noted.


Source Il Messaggero

>>> Banco Popolare CEO sees draft of M&A banking deals in Italy

Banco Popolare CEO sees draft of M&A banking deals in Italy

Pierfrancesco Saviotti, chief executive of listed Italian bank BPI, has seen a new draft of M&A deals in Italy, reported Il Sole 24 Ore. He was quoted as saying that after the European Central Bank closes all the tests that it is conducting on Italian banks (asset quality review and stress tests), there will be more M&A deals in Italy. He said BPI will have an active role in this M&A process. Earlier, this week, BPI had decided to put on hold the sale of Release, its non-performing loans vehicle. Saviotti was quoted as saying that BPI is not in a hurry to sell and that it will separately sell some non performing loans, for which negotiations are ongoing.


Source Il Sole 24 Ore

>>> Barron's Summary: Positive on IP, NTAP, ADBE ; Cautious on VLO, RMD

Barron's Summary: Positive on IP, NTAP, ADBE ; Cautious on VLO, RMD 

- Cover story: Barrons list of the Worlds Most Respected Companies is topped by AAPL, BRKA, BA, GOOG, JNJ, DIS, AMZN, V, MA, and MMM; Criteria include operating metrics strong management, ethical business practices, sound business strategy, competitive edge, and product innovation. 

- Tech Trader: Chip stocks have been strong performers, and though the run is likely to cool in coming months, the fundamentals look good for companies themselves, which could power them to new gains in the next 12 months (Positive on AVGO, MRVL, MU, SWKS, TQNT). 

- Trader: Nobel Prize-winning economist Robert Shiller notes the market has looked more expensive on a cyclically adjusted price/earnings basis only three other times in the past 130 years: 1929, 2000, and 2007; Cautious on VLO: Shares are down on news Commerce Department will allow oil producers to export some forms of unrefined crude, but investor concerns may be overblown, and shares are trading at a 15% discount to historic multiple. 

- Features: Positive on IP: Shares of paper and packaging company are among the cheapest in its peer group, and could see a 40% boost as economy recovers and company ramps up dividend payouts and stock buybacks; Positive on NTAP: Company is replacing lower-end OEM sales with lucrative branded sales and is initiating buybacks, which could prompt dirt-cheap shares to rise 25% or more; Positive on ADBE: While peers dithered on cloud computing, company embraced it, creating a subscription program to replace boxed software, a move that has led to steady earnings growth and a potential 20% rise in share price; Cautious on RMD: As Medicare works on ways to limit costs for sleep-apnea treatments, among its top outpatient expenses, company could see profit growth slow and a possible 15% decline in share price. 

- Hedge Funds: Interview with Justin Abercrombie, Portfolio Manager, Schroders Global Value Extension Fund (picks: AAPL, AXA, BNP Paribas, Indo Tambangraya Megah, Legal & General, Vale; pans: Commonwealth Bank of Australia, TSLA, TWTR, Vallourec); Interview with Sarah Ketterer, Co-Founder & CEO, Causeway Capital Management, who is interested in finding companies with profitability and operating leverage (picks: Komatsu, International Consolidated Airlines Group, Schneider Electric); 

- European Trader: Positive on SHPG: Though shares have jumped since ABBV bid, there could be more upside to come, especially if another bidder emerges. 

- Asian Trader: Best performers in Asia in first six months of the year have been South and Southeast Asian markets, including India, Philippines, Indonesia, and Thailand; The biggest risk in Asia remains China, says Markus Rosgen of Citigroup, who likes Asian banks such as MTU; Benjamin Yeo at BCS likes Larsen & Toubro and Hon Hai Precision. 

- Emerging Markets: Value has started to emerge in Chinese property stocks, but it seems premature to jump into a group thats down 12% this year, though nimble investors could short stocks such as China Resources Land, Evergrande, and Country Garden. - Commodities: U.S. oil prices have trailed the West Texas Intermediate benchmarks gains and could retreat more quickly if crisis in Iraq continues. 

- Follow-Up: Headlines seem to suggest Africa is a scary place to invest, but the stock market there tells another story, and many of the countrys stocks are poised for growth (Positive on MTN Group, Shoprite Holdings, Safaricom, FM, AFK, NGE); Positive on NXST, SBGI: Companies are the biggest winners following Supreme Court ruling on Aereo, while large media stocks such as CBS, CMCSA, DIS, FOXA, GCI, and Tribune also stand to benefit. 

- CEO Spotlight: Profile of BAC chief Brian Moynihan, who has focused on cost-cutting, selling non-core assets, and sought ways to increase efficiency across operations. 

- Streetwise: Industrials seem to be benefiting from the pickup in U.S. economic growth, and could see a boost with the first quarter in the rearview mirror (Positive on LLL, CSX, PH).

Télégraph AbbVie scuppers Shire bid for rival

Shire had been lining up a $5bn (£2.9bn) financing package to acquire rare disease business NPS

AbbVie's takeover approach of Shire has scuppered the Irish drugmaker’s attempts to acquire a rival US pharmaceutical company, NPS Pharmaceuticals.

Days before AbbVie’s offer was made public Shire had been lining up a $5bn (£2.9bn) financing package to acquire rare disease business NPS.

However, AbbVie’s confirmation that it had made a £27bn approach for London-listed Shire kicked off a 28 -day offer period meaning the US bidder must make a firm, fully-financed bid by July 18, or walk away.

AbbVie’s initiation of an offer period firmly squeezed the brakes on Shire’s own takeover ambitions because the UK Takeover Code restricts target companies in offer period from acquiring assets which could be deemed as a “frustrating action”.

Shire is therefore unable to make any acquisitions, by which it could bulk itself up and defend its independence.

“Shire is unlike other companies in that it is historically very acquisitive, it is part of its business model”, one person familiar with the company said. “So to be hamstrung in its ability to follow its day-to-day business practice is very disruptive”.

If Shire is reluctant to be sold to AbbVie it could call an emergency meeting of shareholders to approve its own acquisition plan.

However, this would hinge upon Shire’s shareholders believing that a deal by the Dublin-domiciled business would be better than a takeover of Shire.

Flemming Ornskov, chief executive of Shire has been pragmatic about his defence of the business so far and said he would not stand in the way of a deal if a higher offer came from AbbVie.

(Barron's) Markets End Mixed, Bulls Get Uncomfortable

What about the current bull market? It’s been running for more than five years now, and that alone has some questioning how much longer it can go on. Don’t look for answers in the market’s performance this week. The S&P 500 dipped just 0.1% to 1,960.97, while the Dow Jones Industrial Average fell 0.6% to 16,851.84. The Nasdaq Composite gained 0.7% to 4,397.93 and the small-company Russell 2000 ticked up 0.1% to 1,189.50. Make sense of that jumble.

Investech Research’s Jim Stack expresses his discomfort with the five-year bull market:

…with the market hitting new all-time highs almost daily, the majority of dark clouds have seemingly disappeared from the investment horizon. Yet this is when we tend to become most uncomfortable. Not bearish – just uncomfortable. It’s not that we disagree with the evidence – which supports a bullish outlook. We simply know that, historically, market tops are accompanied by maximum levels of bullish consensus. One can’t base their investment decisions solely on "sentiment" or "complacency" – but one also shouldn’t ignore such extremes when they start to appear.

Societe Generale’s Albert Edwards extols the life of a Bear:

I’ve long felt being an equity bear is more like a vocation, especially as I have now been underweight equities for 17½ years. Being an equity bear is about as popular as being an estate agent or indeed even worse – a politician. But I believe we remain trapped in a secular valuation bear market and the Ice Age theme will continue to dominate in the near term. The flip side of this is that I remain a bull of long government bonds. As my colleague Andrew Lapthorne points out, the nature of the beast is that I am wrong 90% of the time as equities outperform bonds, only to be correct in the long term as many years of equity outperformance are savagely unwound in a matter of months.

JPMorgan’s Arjun Mehra and team wrote think there could be some short-term pain ahead after the S&P 500 experienced a "key reversal:"

In general terms, a key reversal occurs when a security completely changes its recent pattern during the course of a trading day. Specifically, for a day to be classified as a key reversal day in an up-trending market, 2 things need to happen: 1) the security must trend higher and take out the previous all-time highs, and 3) the direction must then reverse with the closing tick falling below the previous day’s low price. A reversal day can also occur in a down-trending market, with the exact opposite direction in each step mentioned above.

We looked at price history for the S&P 500 since the beginning of 2000 and discovered that key reversal days in up-trending markets (like the one we are in the midst of currently) are rare and have only occurred in 5 total instances, with June 24, 2014, being the most recent occurrence. The data shows that the S&P 500 underperformed immediately following the triggering of each of these days. As such, we think it is prudent to buy short-dated puts/ put spreads on the index to hedge against any potential downside in the coming few days, particularly with implied volatility close to cycle lows.

(Barron's) Undervalued Oil Giant Chevron Could Rise 30%

Undervalued Oil Giant Chevron Could Rise 30% Years of investment in production should pay off in the coming quarters, rewarding investors who buy low.

Oil giant Chevron has spent the past few years investing in its future, which has created a powerful opportunity for investors. A capital-spending blitz has depressed the company's earnings in the short term, keeping a lid on the share price. Meanwhile, the payoff will be greater profits down the road to share with investors wise enough to get in now.

Chevron (ticker: CVX ) is poised for a resurgence of profits in late 2014 and beyond as it wraps up years of successful exploration and large project construction amid an environment of high oil prices.

"Chevron offers by far the best growth prospects in the integrated oil sector with visibility through 2020, and the stock is still reasonably valued, especially relative to Exxon," says Jefferies analyst Jason Gammel. "The dividend is very sustainable and capable of growing in the mid- to high-single digits on an annual basis." Shares yield 3.2%.

At 11.7 times forward earnings, Chevron is significantly cheaper than ExxonMobil ( XOM ) and ConocoPhillips ( COP ), which both trade well above 13 times forward, even as Gammel estimates Chevron's annual cumulative production growth rate as high as 5.5% through the end of the decade, well ahead of the 1% to 2% industry average.

Chevron's stock has been held back in part by concerns over its big capital spending program. However, investment in exploration will benefit shareholders for years to come, and two major Australian liquefied natural gas projects, Gorgon and Wheatstone, are set to come online in the next two years: At full capacity, Gorgon alone could generate around $1.30 in annual earnings. (Chevron earned $11.09 a share in 2013.)

Jim Kee, South Texas Money Management's chief economist, says that Chevron is showing "great discipline" in spending wisely while continually rewarding shareholders. Chevron is "reinvesting in projects that will increase the value of the company but depressing earnings in the short term — that creates an opportunity for investors to jump in and buy the stock, and now is the perfect time to do that."

Some investors may be hesitant to buy now, but Kee argues that "Most of its spending will start to generate cash flow over the next few years, and the market hasn't priced that in yet. So the return on investment will go up, the market will start to reward the stock, and people who own the stock now will see a good 30% return." After a dip in 2014, Chevron is expected to return to mid-single-digit earnings-per-share growth in 2015 and earn $12.31 a share in 2016.

Moreover, while Chevron is expanding its natural gas production, it is still one of the "oiliest" majors: More of its earnings come from oil, which is more stable in price than natural gas — and its contracts mean that much of its LNG output is also tied to oil prices.

"We believe that Chevron is the most levered of the majors to higher oil prices…and oil is well supported, not just because of [recent instability] in Iraq, but as the actual physical balances of oil are very tight, inventories are very low," says Brian Bradshaw, portfolio manager of the BP Capital TwinLine Energy Fund, which counts Chevron among its top five holdings.

Bradshaw also notes that Chevron is one of the few majors aggressively investing in its business at the moment, with the rest of the group focusing on shareholder returns. With both dividends and buybacks, Chevron's total yield is just under 5%, while Exxon is closer to 6%.

Yet receiving a slightly smaller yield now allows Chevron shareholders to get the better-earning company in the long run. "The money they are spending now shows up in better production volumes and better margins in the years to come -- because of rising oil prices and cost controls -- so you end up with a company that [will ultimately] have higher dividends and stock buybacks, and Chevron's return on capital is already one of the best in the business," says Bradshaw.

To be sure, investors have to be comfortable with execution risk before buying the stock. Despite its seasoned management team and disciplined approach, Chevron has to watch costs carefully -- a difficult task with big projects like those in Australia. And as with any major integrated oil company, some of its assets are in riskier regions, in geopolitical terms. Finally, a crash in oil prices would also hurt the stock.

Yet any missteps are likely to be minor and short term, and with large, valuable assets in stable places such as the U.S. and Australia, Chevron isn't as exposed to international politics as some peers. Nor does the company draw any of its earnings from Iraq, which, along with other factors, is working to keep oil prices up.

Chevron  (CVX)

Stock Price: $130.92 52-Week High: $133.57 52-Week Low: $109.27 Market Value: $250 billion Est. 2014 EPS:$10.86 Fwd P/E: 11.7 Est. Long-Term EPS Growth:*5.50% Est. ('14/'13) EPS Growth: -2% Revenue (trailing 12 months):$208 billion Dividend Yield: 3.30% CEO: John Watson Headquarters:San Ramon, Calif. * Based on analyst estimates looking ahead three to five years. Sources:  Barron's, Thomson Reuters, Yahoo Finance

>>> Weekly Market Update: Summer Doldrums Arrive Early

Weekly Market Update: Summer Doldrums Arrive Early

- The second quarter still has one session left to go on Monday, however there was very little quarter-end repositioning driving trading volumes or volatility any higher this week. The final reading of first quarter US GDP came in much lower at -2.9%, however markets ignored this well-trodden story to concentrate on more recent, more positive numbers: the May Markit manufacturing PMI reading pushed out to 61, its highest level since May 2010; May new home sales surged 18.6% from April to an adjusted rate of 504K, the highest level since 2008; and May core PCE at 1.5%. Similarly positive data were seen out of China and Japan, while European indicators held steady at a low level of growth and inflation. The S&P500 made an all-time intraday high on Tuesday and then edged lower, while European bourses moved lower all week. For the week, the DJIA dropped 0.6%, the S&P500 fell 0.1% and the Nasdaq gained 0.7.

- The annualized May core PCE, the Fed's preferred measure of inflation, grew 1.5%, right in line with consensus expectations. This is the highest rate of growth in the measure since February 2013, and the overall reaction to the data among analysts and the Fed was very measured this week. The headline PCE was a bit higher, at 1.8%. Fed dove Bullard said PCE inflation would not get above 2% until 2015 but warned that the Fed is much closer to achieving its goals and the economy is doing much better than most people realize. While Bullard also reiterated his view that rate hikes would not be appropriate until the first quarter of 2015, Bullard's firm tone helped force equity markets lower on Thursday morning. Fed hawk Lacker said the recent inflation data was not just "noise" and that inflation measures would head higher this year. Lacker also warned it would be a mistake to allow inflation to get out of control before the Fed started raising rates. Recall that last week, Fed Chair Yellen said "...recent readings on, for example, the CPI index have been a bit on the high side, but I think the data we're seeing is noisy."

- The final revision of the weather-impacted US first quarter GDP missed expectations and sank much lower, to -2.9% from the -1.0% preliminary figure. This was the fastest rate of decline since the Great Recession and the largest drop recorded since the end of World War II that wasn't part of an official recession. However, nearly every component of the final reading was very modestly adjusted with the exception of imports and exports (which more or less cancelled each other out), and the services PCE, which was revised to +1.5% from +4.3% in the preliminary data, driven entirely by updated estimates of health care spending. The feds had assumed medical services would be up sharply due to expanded access under the ACA, but the latest quarterly services survey showed few signs of acceleration. After the data, Barclays adjusted its call to +2.9% from +4% in its prior view, to reflect a more modest rebound in Q2 consumption growth. TD Ameritrade cut its Q2 GDP view to +3.0% from +3.6% prior.

- Oil prices spiked higher on Tuesday on reports the Obama administration had cleared the way for the first exports of US crude oil in 40 years. Federal officials informed two energy firms - Pioneer Natural Resources and Enterprise Products Partners - they can legally export ultra-light oil condensate, which is a product of shale drilling. The front-month WTI crude contract traded as high as $107.50 before the Commerce Department clarified that there had been no broad change in policy. Commerce said that the two companies were granted permission to export shale condensate only after it had been run through a distillation tower to become a petroleum product and only because of a large oversupply of condensate, clarifying that the move had no larger implications for crude exports. Nevertheless, refiners tanked on Wednesday, with Valero down 10% or so on the week.

- On Friday Ukraine signed the historic free-trade agreement with the European Union that has been at the heart of months of violence and upheaval in the country, drawing an immediate threat of "grave consequences" from Russia. Ukraine President Poroshenko declared a unilateral ceasefire for the week, however hostilities continued, with both sides exchanging fire on several occasions. The tentative ceasefire is expected to extend through Monday to allow of an attempt at peace talks. Western powers reiterated they stand ready to impose more sanctions if Russia fails to make a good faith effort de-escalate the tensions and return full control of Ukraine's border to the Kiev government.

- The US Supreme Court ruled against Barry Diller's Aereo streaming television service, calling it a broad violation of broadcaster copyrights. The sweeping and definitive ruling was split 6 to 3, and the majority opinion went out of its way to call out Aereo as the equivalent of a cable company, not merely an equipment provider. They also emphasized that the ruling does not endanger other technologies, including cloud computing technology. Mr. Diller said the ruling was the end of the road for Aereo, calling the ruling a big loss for consumers.

- In earnings, shares of Nike gained ground on impressive fourth quarter numbers, beating on the top and bottom line. Futures orders were up 11%, while even China - previously a soft spot - appears to have made a fully recovery from its inventory adjustment with a 4% rise in sales. Walgreen missed bottom-line expectations in its third quarter, but bevenue was up 6% y/y and met consensus views while Rx comps were up 6.3%. Walgreen also said it was considering reincorporating in Switzerland for tax reasons as part of its combination with Alliance Boots. Monsanto beat earnings expectations in its third quarter results and authorized a big new share buyback program. Note that earnings were down 5% y/y and revenue missed expectations, dragged lower by a 16% y/y decline in sales of genetically-engineered corn seeds. Homebuilders Lennar and KB Homes reported very strong quarterly results, with robust gains in new home sales and strong growth in backlogs.

- In M&A news, France's Alstom accepted General Electric's $13.5 billion offer to acquire the firm's power generation and grid businesses, with the additional caveat that GE enter three JVs with Alstom for grid infrastructure, renewable power equipment and nuclear power. The deal comes after the French government got an option to buy as much as 20% of Alstom from Bouygues following the closing of the deal, giving the government the guarantee it needed that Alstom will remain a French firm. Oracle reached a deal to acquire Micros Systems for $68/share in cash, in a total deal valued at $5.3B. This is the company's biggest buy since acquiring Sun Microsystems for $7.4 billion back in 2009. Midwest utilities Wisconsin Energy and Integrys Energy entered an all-stock merger valued at $9.1 billion.

- FX markets remained locked in tight ranges for yet another week as volatility declined even further. Analysts noted as long as US bond yields were in retreat and the US yield curve continued its bullish steepening, the greenback should stay offered, pushing volatility even lower and keeping the carry trade in play. Volatility in the EUR/USD pair matched all-time lows at 4.55%. GBP/USD saw a little profit-taking after failing to close above the pivotal 1.7050 weekly chart point. USD/JPY slid lower, dropping below its 200-day moving average to end the week around 101.34 largely due to US rates. Key support is at 100.70 and could ignite downside momentum if broken.

- China HSBC flash manufacturing PMI for June returned to expansionary territory for the first time in six months, signaling the "targeted mini-stimulus" measures orchestrated by policymakers are starting to gain some traction. The data showed an upward inflection in input prices and improvement in the employment component, although growth in new export orders slowed. HSBC chief China economist said he expects continued accommodative policy until the recovery is sustained. China Beige Book assessment of Q2 was more measured, indicating fewer companies had access to credit amid weakening investment environment. Shanghai Composite ended the week up 0.5%.

- Trading in Tokyo was decidedly more bearish as Nikkei225 fell 1.7%, weighed down by firmer Yen and even more fodder for the BOJ to stick to its guns on policy. May unemployment rate fell to a 17-year low of 3.5%, while job-to-applicant ratio hit a 22-year high of 1.09x. Inflation figures also maintained their upward trend, with core Japan-wide CPI reaching its highest point since 1982. Japan PM Abe formally unveiled his "3rd arrow" plans early in the week, announcing plans to cut the corporate tax rate from current 35%+ to below 30% over the next few years, enact portfolio management reforms for pension funds, and revise the tax system with intent on promoting the number of women in the workforce.